Stay updated on Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page.

Latest updates to the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedPubMed publications section wording updated to indicate that publications are auto-filled from PubMed, replacing the previous description. The revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check26 days agoChange DetectedDeleted the general operating status notice about a lapse in government funding that could affect updates; this does not change trial data or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedThe newer screenshot shows added results sections (e.g., adverse events, response and survival metrics) and expanded study plan/eligibility criteria for the trial.SummaryDifference0.4%

- Check69 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference3%

- Check76 days agoChange DetectedUpdate to v3.1.0; removal of two specific medical condition entries (Head and neck squamous cell carcinoma and Melanoma, Cutaneous Malignant) from the page.SummaryDifference0.3%

- Check91 days agoChange DetectedRevision updated to v3.0.2 and Back to Top removed; no core content or critical information is affected.SummaryDifference0.2%

Stay in the know with updates to Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page.